spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Revascularization 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 7 Jan 2025
Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment
Devices Interventional
 HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 1 May 2023
Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 11 Jan 2023
MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE approval, its fourth FDA IDE DEB Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 10 May 2022
Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism (PE)
Devices Interventional
 HSMN NewsFeed - 10 Mar 2022
S.M.A.R.T. RADIANZ(TM) Vascular Stent System Approved for Transradial Use in the U.S.
Devices Interventional FDA
 HSMN NewsFeed - 8 Oct 2021
18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR(TM) Presented as Late Breaking Trial at VIVA
Devices Interventional
 HSMN NewsFeed - 26 Jul 2021
Medtronic Launches Newest-Generation Drug Coated Balloon Catheter in Europe for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 1 Feb 2021
Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems
Devices Cardiology Surgery Personnel
 HSMN NewsFeed - 25 Jan 2021
PEDRA(TM) Technology Receives FDA Breakthrough Device Designation for its PEDRA(TM) Xauron(TM) Real-Time Tissue Perfusion System
Devices Monitoring FDA
 HSMN NewsFeed - 11 Jan 2021
Marizyme Announces the Use of DuraGraft(R) as the Standard-of-Care in Patients Undergoing Coronary Artery Bypass Surgery (CABG) at Vienna Heart Center North Floridsdorf
Devices Cardiology
 HSMN NewsFeed - 4 Dec 2020
Marizyme, Inc. Expands Executive Team, Board of Directors
Devices Surgery Cardiology Personnel
 HSMN NewsFeed - 9 Nov 2020
The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
Devices Interventional
 HSMN NewsFeed - 6 Nov 2020
Marizyme, Inc. Appoints Dr. Neil J. Campbell, as CEO, President and Member of Board of Directors
Devices Surgery Personnel
 HSMN NewsFeed - 2 Nov 2020
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon
Devices Interventional FDA Product Launch
 HSMN NewsFeed - 29 Sep 2020
Cardiac Dimensions Announces $17.5 Million Series C Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System(R)
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 23 Sep 2020
OrbusNeich(R) Announces China Approval for COMBO(R) Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Aug 2020
Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 10 Jul 2020
World's First FDA IDE Coronary Patient Treated With a DEB
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 May 2020
Jeffrey J. Popma, M.D. to Join Medtronic as Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart Businesses
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 6 Jan 2020
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
Devices Interventional Acquisitions
 HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Biopharmaceuticals Cardiology Reimbursement
 HSMN NewsFeed - 25 Sep 2019
OrbusNeich(R) Announces Japan Approval for COMBO(R) Plus Coronary Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Sep 2019
CHMP Issues Positive Opinion to Expand Trulicity(R) (dulaglutide) Label to Include Results from REWIND Cardiovascular Outcomes Trial
Biopharmaceuticals Endocrinology Cardiology Regulatory
 HSMN NewsFeed - 6 Aug 2019
CeloNova Announces Appointment of New President and CEO
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 12 Jul 2019
Neovasc to Explore HDE Approval Pathway and Alternate Trial Designs for the Reducer Following Guidance from the FDA
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 24 Jun 2019
Micro Medical Solutions Receives FDA IDE Approval for Pivotal Clinical Trial of MicroStent
Devices Interventional FDA
 HSMN NewsFeed - 18 Apr 2019
TELA Bio(R) Announces 510(k) Clearance for Restella(TM) Reconstructive BioScaffolds for Reconstructive Surgery
Devices Surgery FDA
 HSMN NewsFeed - 20 Feb 2019
Neovasc Provides Corporate Update
Devices Interventional Cardiology Litigation
 HSMN NewsFeed - 11 Feb 2019
Pierangeli Clinic Initiates Program Providing Neovasc Reducer(TM) Procedure to Italian Patients with Refractory Angina
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Oct 2018
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2018
Boston Scientific Receives U.S. FDA Approval for the Eluvia(TM) Drug-Eluting Vascular Stent System
Devices Interventional FDA
 HSMN NewsFeed - 28 Aug 2018
European Society of Cardiology incorporates iFR technology into updated guidelines for revascularization
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology
 HSMN NewsFeed - 15 Aug 2018
Medtronic Announces Commercial Launch of the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon in Japan
Devices Interventional Product Launch
 HSMN NewsFeed - 20 Jun 2018
Neovasc Announces First Implant of a Neovasc Reducer(TM) in a U.S. Patient
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jun 2018
Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons
Devices Interventional FDA
 HSMN NewsFeed - 12 Jun 2018
MicroVention Announces FDA Clearance For Thrombectomy Device
Devices Interventional Neurology FDA
 HSMN NewsFeed - 22 May 2018
Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
Devices Interventional Radiology Neurology FDA
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 26 Feb 2018
Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 15 Feb 2018
Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders
Devices Interventional Neurology Venture Capital
 HSMN NewsFeed - 1 Feb 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 9 Jan 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Devices Surgery Product Launch
 HSMN NewsFeed - 6 Nov 2017
Neovasc Receives FDA Approval to Initiate Pivotal Reducer Trial
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Oct 2017
Nitiloop Announces FDA 510(k) Clearance for its Nova Cross Extreme and Nova Cross BTK Micro catheter for Support of Guidewire Access to Discrete Regions of the Coronary and Peripheral Vasculature
Devices Interventional FDA
 HSMN NewsFeed - 11 Oct 2017
Silk Road Medical Appoints World Class Stroke Prevention Champion to Serve as Vice President, Medical Affairs and Professional Education
Devices Neurology Personnel
 HSMN NewsFeed - 7 Sep 2017
Johnson & Johnson Medical Devices Companies Signals Commitment to Stroke Treatment With the Announcement of New Neurovascular Business
Devices Neurology Interventional
 HSMN NewsFeed - 5 Sep 2017
Neovasc's Reducer System Reviewed in European Heart Journal
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2017
ESC Congress 2017: BIOTRONIK's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Aug 2017
Getinge announces full U.S. availability of Pulsar(R)-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease
Devices Interventional Product Launch
 HSMN NewsFeed - 3 Aug 2017
VM BioPharma Announces First Patient Dosed in Phase 3 Study of Gene Therapy Candidate VM202 for Non-Healing Diabetic Foot Ulcers
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 28 Jul 2017
FDA Grants Priority Review For Amgen's Supplemental Biologics License Application For Repatha(R) (evolocumab) To Include Data On Reducing Risk Of Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Jul 2017
Silk Road Medical Announces $47 Million Financing led by Norwest Venture Partners and Funds Managed by Janus Capital Management LLC
Devices Interventional Radiology Venture Capital
 HSMN NewsFeed - 3 Jul 2017
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
Devices Interventional
 HSMN NewsFeed - 16 May 2017
Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 10 Apr 2017
Codman Neuro Announces Acquisition Of Neuravi Limited To Accelerate Innovation In Acute Ischemic Stroke Therapy
Devices Neurology Interventional Mergers & Acquisitions
 HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 Mar 2017
New Study Finds Abiomed Impella(R) Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Mar 2017
CeloNova Biosciences Receives FDA Approval of COBRA PzF(TM) Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Nov 2016
Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries
Devices Interventional Venture Capital
 HSMN NewsFeed - 20 Oct 2016
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA(TM) Bioresorbable Scaffold for Peripheral Vascular Disease
Devices Interventional
 HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional
 HSMN NewsFeed - 10 Oct 2016
St. Jude Medical Announces FDA Clearance and Launch of the New PressureWire X Guidewire Designed to Optimize PCI Procedures in Patients With Complex Anatomies
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 8 Sep 2016
Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke
Devices Neurology Interventional Product Launch
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 17 Jun 2016
ARIAD Announces Distribution Agreements for Iclusig(R) in Latin America and the Middle East/North Africa
Biopharmaceuticals Distribution
 HSMN NewsFeed - 2 Jun 2016
ARIAD Completes the Sale of Its European Operations and Out-License of European Rights to Iclusig(R)
Biopharmaceuticals Oncology Licensing Acquisitions
 HSMN NewsFeed - 8 Feb 2016
STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Devices Interventional Product Launch
 HSMN NewsFeed - 3 Feb 2016
Maquet Medical Systems USA, A Getinge Group Company Announces Partnership with BIOTRONIK to Distribute Endovascular Medical Devices in United States
Devices Interventional Distribution
 HSMN NewsFeed - 14 Jan 2016
Contego Medical Announces European Commercialization of the Paladin(R) Carotid Post-Dilation Balloon with Integrated Embolic Protection(TM) Technology
Devices Interventional Product Launch
 HSMN NewsFeed - 10 Dec 2015
Antonio Colombo, MD appointed Member of the Scientific Advisory Council of Miracor Medical Systems
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 5 Nov 2015
Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke
Devices Neurosurgery Interventional
 HSMN NewsFeed - 20 Oct 2015
Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes
Devices Interventional Venture Capital
 HSMN NewsFeed - 5 Oct 2015
Boston Scientific Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Sep 2015
Thoratec Announces Start Of Shield II(TM) U.S. Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Jul 2015
Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology
Devices Interventional
 HSMN NewsFeed - 24 Jul 2015
Regeneron and Sanofi Announce FDA Approval of Praluent(R) (alirocumab) Injection, the First PCSK9 Inhibitor in the U.S., for the Treatment of High LDL Cholesterol in Adult Patients
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 13 Jul 2015
Thoratec Receives CE Mark Approval For HeartMate PHP(TM)
Devices Cardiology Regulatory
 HSMN NewsFeed - 10 Jul 2015
Sorin Group Announces Global Launch of Its Latest Generation of Heating and Cooling Systems at FECECT 2015
Devices Cardiology Product Launch
 HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 17 Jun 2015
Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy
Devices Neurology Interventional Venture Capital
 HSMN NewsFeed - 19 May 2015
FDA Grants Premarket Approval for Silk Road Medical's ENROUTE(R) Transcarotid Stent System
Devices Interventional FDA
 HSMN NewsFeed - 29 Apr 2015
Intact Vascular’s First-In-Man Clinical Study Results Published in the Journal of the American College Of Cardiology: Cardiovascular Interventions
Devices Interventional
 HSMN NewsFeed - 17 Apr 2015
Global Trials Show Addition of Medtronic’s Solitaire(TM) Device Stent Thrombectomy Procedure in Treatment of Acute Ischemic Stroke Improves Neurological Outcomes
Devices Interventional Neurology
 HSMN NewsFeed - 14 Apr 2015
Hansen Medical(R) Receives CE Mark for Magellan(TM) 10Fr Robotic Catheter
Devices Interventional Regulatory
 HSMN NewsFeed - 12 Mar 2015
CryoLife Provides Update on PerClot Litigation
Devices Surgery Litigation
 HSMN NewsFeed - 10 Feb 2015
Silk Road Medical Announces FDA 510(k) Clearance of the ENROUTE(R) Transcarotid Neuroprotection System
Devices Interventional FDA
 HSMN NewsFeed - 27 Jan 2015
Spectranetics Completes Acquisition of Stellarex(TM) Drug Coated Balloon Assets From Covidien
Devices Interventional Acquisitions
 HSMN NewsFeed - 21 Jan 2015
Integra LifeSciences Launches Integra(R) Reinforcement Matrix
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 18 Sep 2014
World’s First Integrated Delivery System Meets All Endpoints in the Direct II Randomized, Controlled Drug-Eluting Coronary Stent Study
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Sep 2014
First-In-Man Study of the COBRA PzF(TM) Coronary Stent Shows Promising Results Highlighted by Short, 30-Day Dual-Antiplatelet Therapy and Low, 3% TLR Rate
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jul 2014
CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 16 Jul 2014
First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO(TM) Dual Therapy Stent and OrbusNeich's Clinical Programme
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jul 2014
CryoLife Appoints Pat Mackin as President and Chief Executive Officer
Devices Surgery Personnel
 HSMN NewsFeed - 23 May 2014
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2014
Covidien Releases Two-Year Study Results Demonstrating Sustained Effectiveness of Drug-Coated Angioplasty Balloon Technology
Devices Interventional
 HSMN NewsFeed - 21 May 2014
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
Devices FDA
 HSMN NewsFeed - 27 Mar 2014
CryoLife Acquires Distribution Rights and Purchase Option for ProCol(R) Vascular Bioprosthesis for Hemodialysis Access
Devices Distribution
 HSMN NewsFeed - 12 Mar 2014
Toshiba’s Exclusive CT Myocardial Perfusion Helps Produce Faster and Safer Cardiac Diagnoses
Devices Radiology Cardiology FDA
 HSMN NewsFeed - 13 Feb 2014
Medtronic Launches 'TOTAL Across' Crossing Catheter in Europe
Devices Interventional Product Launch
 HSMN NewsFeed - 14 Jan 2014
ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jan 2014
FDA Reclassifies ECP Devices for Refractory Angina as Class II
Devices Cardiology FDA
 HSMN NewsFeed - 2 Dec 2013
Siemens Launches Artis one Angiography System for Universal Use
Devices Radiology Product Launch
 HSMN NewsFeed - 20 Nov 2013
MAQUET Cardiovascular Announces Study Results Demonstrating HEARTSTRING(R) Device Associated with Significant Reduction in Coronary Artery Bypass Stroke Risk
Devices Surgery Cardiology
 HSMN NewsFeed - 6 Nov 2013
Gore Receives FDA Approval for 25 cm GORE(R) VIABAHN(R) Endoprosthesis
Devices Interventional FDA
 HSMN NewsFeed - 6 Nov 2013
Neovasc Reducer(TM) Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients with Refractory Angina
Devices Cardiology
 HSMN NewsFeed - 9 Oct 2013
First Patient Enrolled in Phase III Trial Evaluating The Medicines Company's Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular Procedures
Biopharmaceuticals Interventional
 HSMN NewsFeed - 24 Sep 2013
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Devices Interventional FDA
 HSMN NewsFeed - 27 Aug 2013
Sunshine Heart Welcomes Dr. Patrick Verta as Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 6 Aug 2013
First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent(TM) in Routine Practice
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Jul 2013
CryoLife Receives FDA Premarket Approval (PMA) for New Sologrip Minimally Invasive TMR Laser Fiber-Optic Delivery System
Devices Cardiology FDA
 HSMN NewsFeed - 9 Jul 2013
CryoLife Enhances International Presence with Appointment of Andres Sarmiento as Latin America Sales Manager
Devices Surgery Cardiology Personnel
 HSMN NewsFeed - 19 Jun 2013
AngioScore Announces Completion of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Jun 2013
RTI Biologics(R) Launches Fortiva(TM) Porcine Dermis, First Human Implantation Complete
Devices Surgery Product Launch
 HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology
 HSMN NewsFeed - 24 May 2013
Elixir Medical Corporation Announces Outstanding Two-Year Results from the EXCELLA BD Randomized Clinical Trial for the CE Mark-Approved DESyne(R) BD System with Biodegradable Polymer Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2013
Boston Scientific Promus PREMIER(TM) and SYNERGY(TM) Drug-Eluting Stent Systems Provide Exceptional Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2013
St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 8 May 2013
Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne(R) Nx Novolimus Eluting Coronary Stent System in the United States
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Apr 2013
CryoLife Receives FDA Clearance For Next Generation HeRO Device
Devices FDA
 HSMN NewsFeed - 14 Feb 2013
Miracor Granted Five Additional U.S. Patents and One Additional European Patent for Its PICSO(R) System to Treat Severe Heart Attack Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Jan 2013
IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions
Devices Interventional
 HSMN NewsFeed - 24 Jan 2013
Final Results of Spectranetics Study Supports Successful Use of Laser Atherectomy for Treating Patients With Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 14 Jan 2013
Covidien Opens Patient Enrollment for SWIFT PRIME Acute Ischemic Stroke Study
Devices Neurology Interventional
 HSMN NewsFeed - 18 Dec 2012
St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Dec 2012
Covidien’s Solitaire(TM) FR Revascularization Device Receives Regulatory Approval in Canada
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 4 Dec 2012
Clinical study results using Miracor’s PICSO(R) system show potential to treat severe heart attack (STEMI) patients and are published in December’s Journal of Interventional Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Nov 2012
Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Nov 2012
S.M.A.R.T.(R) Vascular Stent Systems Receive FDA Approval for Use in SFA
Devices Interventional FDA
 HSMN NewsFeed - 31 Oct 2012
Boston Scientific Receives CE Mark Approval for the SYNERGY(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Oct 2012
Elixir Medical Corporation Announces Outstanding Three-Year Data from the EXCELLA II Randomized Clinical Trial for the CE Mark-Approved DESyne(R) System
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific Epic(TM) Stent Continues to Demonstrate Positive Clinical Outcomes for Patients with Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 23 Oct 2012
The Boston Scientific PROMUS Element(TM) Platinum Chromium Stent Demonstrates Positive Outcomes in Patients with Long Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2012
STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing(R) Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 22 Oct 2012
STENTYS Self-Apposing(R) Stent Continues to Demonstrate Low Mortality at One Year in APPOSITION III Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Aug 2012
CardioDx Completes $58 Million Equity Financing
Diagnostics Cardiology Venture Capital
 HSMN NewsFeed - 27 Aug 2012
MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
Devices Cardiology
 HSMN NewsFeed - 13 Aug 2012
Cook Medical’s Ongoing Zilver(R) PTX(R) Trial Data Show Higher Freedom From Target Lesion Revascularization (TLR) Rates Compared to Angioplasty and Bare Metal Stenting After Three Years
Devices Interventional
 HSMN NewsFeed - 7 Aug 2012
Abbott's Omnilink Elite(R) Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 5 Jun 2012
Asher Holzer Retires as President of InspireMD
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Jun 2012
Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element(TM) Plus Platinum Chromium Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Devices Interventional Cardiology Endocrinology
 HSMN NewsFeed - 24 May 2012
Stryker Announces Positive Clinical Results From The Trevo(R) Retriever System
Devices Interventional
 HSMN NewsFeed - 23 May 2012
Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2012
PROMUS Element(TM) Stent Demonstrates Excellent Long-Term Safety and Effectiveness in PLATINUM Small Vessel Study
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 16 May 2012
BIOTRONIK's Bioabsorbable Magnesium Scaffold Continues to Show Strong Results at 12 Months With Uncompromised Device Usability
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
CryoLife to Acquire Hemosphere
Devices Mergers & Acquisitions
 HSMN NewsFeed - 15 May 2012
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY(TM) Stent Versus PROMUS Element(TM) Platinum Chromium Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Abbott's XIENCE PRIME(TM) and XIENCE V(R) Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 14 May 2012
St. Jude Medical Continues Strong Show of PCI Optimization Technologies at EuroPCR
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2012
Kerberos to Sell FDA Cleared Rinspiration Technology
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Apr 2012
Medtronic Announces Global Drug-Eluting Balloon Study
Devices Interventional
 HSMN NewsFeed - 9 Apr 2012
Abbott Receives Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 23 Mar 2012
St. Jude Medical Announces Next-Generation PressureWire for FFR Measurement
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 7 Mar 2012
Abbott's Absolute Pro(R) Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 5 Mar 2012
Covidien Revascularization Device Receives FDA Clearance
Devices Interventional Neurology FDA
 HSMN NewsFeed - 28 Feb 2012
Miracor receives $3.5 million cash infusion to begin pivotal clinical “RAMSES” trial of its PICSO system, designed to improve myocardial perfusion following primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Feb 2012
Spectranetics Announces Interim Results from German Study Treating Patients with Peripheral In-Stent Restenosis
Devices Interventional
 HSMN NewsFeed - 1 Feb 2012
Boston Scientific Announces First Implant and Market Launch of PROMUS Element(TM) Plus Stent System in Europe
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2012
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
Regenerative Medicine Cardiology
 HSMN NewsFeed - 30 Jan 2012
Covidien Revascularization Device Approved for Interventional Management of Stroke Trial
Devices Interventional Neurology
 HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Jan 2012
Independent Data Safety Monitoring Board Recommends St. Jude Medical’s FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis
Devices Cardiology
 HSMN NewsFeed - 16 Jan 2012
Boston Scientific Epic(TM) Stent Demonstrates Positive Clinical Outcomes in Orion Trial
Devices Interventional
 HSMN NewsFeed - 5 Jan 2012
OrbusNeich's Genous(TM) Stent Achieves Good, Comparable Clinical Outcomes in Patients Discontinuing Dual Antiplatelet Therapy at 30 Days and at Six Months
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Jan 2012
Novadaq Names MAQUET Cardiovascular Exclusive U.S. Distributor of CO2 Heart Laser Products
Devices Cardiology Distribution
 HSMN NewsFeed - 20 Dec 2011
Tryton Announces DRG Reimbursement Code for Side Branch Stent in Germany
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 14 Dec 2011
AngioScore Announces Successful Initiation of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Dec 2011
Abbott Initiates Clinical Trial to Evaluate the Absorb(TM) Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Dec 2011
Data Published in EuroIntervention Indicate that OrbusNeich's Genous(TM) Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology
 HSMN NewsFeed - 4 Nov 2011
Miracor to Report Successful Clinical Study Results of Its PICSO(R) System Designed to Improve Myocardial Perfusion Following Primary PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Nov 2011
Bayer HealthCare's MEDRAD Interventional Business Announces Five-Year Data of Cotavance(R) Drug Eluting Balloon with Paccocath(R) Technology to be Presented at 2011 TCT
Devices Interventional
 HSMN NewsFeed - 1 Nov 2011
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Oct 2011
St. Jude Medical Announces FDA Clearance of First and Only Combined FFR and OCT System
Devices Cardiology FDA
 HSMN NewsFeed - 5 Oct 2011
Boston Scientific Begins Clinical Trial Enrollment for OMEGA(TM) Platinum Chromium Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Sep 2011
Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device
Devices Interventional
 HSMN NewsFeed - 8 Sep 2011
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia
Devices
 HSMN NewsFeed - 8 Sep 2011
Concentric Medical Completes Enrollment in Prospective Multi Center Stentriever Trial for Mechanical Thrombectomy in Stroke
Devices Neurology Interventional
 HSMN NewsFeed - 19 Jul 2011
SANUWAVE Announces American Medical Association Approval of CPT Category III Codes for Extracorporeal Shock Wave Technology in Wound Healing
Devices Wound Care Reimbursement
 HSMN NewsFeed - 18 Jul 2011
OrbusNeich's Genous Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Jul 2011
St. Jude Medical Announces European Approval of First and Only Combined FFR and OCT System
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jul 2011
Boston Scientific Completes Clinical Trial Enrollment for Adapt Monorail Carotid Stent System
Devices Interventional
 HSMN NewsFeed - 17 Jun 2011
Penumbra, Inc. Receives Shonin Approval for the Penumbra System(R) in Japan for Use in the Revascularization of Patients with Acute Ischemic Stroke
Devices Interventional Neurosurgery Regulatory
 HSMN NewsFeed - 13 Jun 2011
Pathway Medical Technologies Expands JETSTREAM G3 SF Family With FDA 510(k) Clearance for 1.6 mm Catheter
Devices Interventional FDA
 HSMN NewsFeed - 20 May 2011
Tryton Announces Positive Data from Three European Registries
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2011
PROMUS Element Stent Demonstrates Exceptional Safety and Effectiveness in PLATINUM Small Vessel Study
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2011
Cost Effectiveness Study Determines FFR Can Improve Health while Reducing Economic Burden in UK, France and Italy
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2011
Industry’s First Hybrid Drug-Eluting Stent from BIOTRONIK Demonstrates Safety and Efficacy in First-in-Man Clinical Experience
Devices Interventional Cardiology
 HSMN NewsFeed - 18 May 2011
Tryton Announces CE Mark for Larger-Diameter Sizes of Side Branch Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Apr 2011
St. Jude Medical Sponsored Study Determines FFR Can Improve Health while Reducing Economic Burden to German Healthcare System
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Apr 2011
Spectranetics to Initiate Landmark Randomized Study of Laser Treatment for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 4 Apr 2011
Boston Scientific's Promus Element Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
Medtronic Resolute(R) Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Apr 2011
BIOTRONIK Announces Positive 6-month Results for Pantera(R) Lux Paclitaxel Releasing Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2011
Pathway Medical Technologies Announces Enrollment of First Patient in JETSTREAM G3 Calcium Study
Devices Interventional
 HSMN NewsFeed - 23 Mar 2011
Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich's Genous Stent in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
Diagnostics Biopharmaceuticals Surgery Cardiology
 HSMN NewsFeed - 22 Feb 2011
Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeich's Genous Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Feb 2011
Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial
Devices Neurology Interventional
 HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 24 Jan 2011
Boston Scientific Completes Enrollment in EVOLVE Clinical Trial to Evaluate SYNERGY Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jan 2011
AxoGen Signs Brad Hedger as Vice President of Sales
Devices Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 10 Jan 2011
Safety and Efficacy of OrbusNeich's Genous Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2010
Economic Evaluation of FAME Trial Confirms Using FFR in Treatment of Coronary Artery Disease Is Cost-Effective
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2010
OrbusNeich's Genous Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Dec 2010
Abiomed Receives Conditional FDA Approval for Study with Impella 2.5 in Reducing Heart Muscle Damage Following PCI in STEMI Patients
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 9 Nov 2010
Miracor reports successful first-in-man clinical outcome for its PICSO(R) system designed to improve acute coronary syndrome (ACS) revascularization following primary percutaneous coronary intervention (PCI)
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Nov 2010
Atrium Announces Completion of Patient Enrollment for the iCARUS Covered Stent Trial for PAD Patients Who Suffer Acute or Chronic Leg Pain
Devices Interventional
 HSMN NewsFeed - 29 Oct 2010
Tryton Presents Positive Six-Month Results for Side Branch Stent System at European Bifurcation Club Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2010
Tryton Announces First Patient Enrollment in E-Tryton Italy Registry of the Tryton Side Branch Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Sep 2010
Minnow Medical Names Raymond W. Cohen as Chief Executive Officer
Devices Interventional Personnel
 HSMN NewsFeed - 30 Sep 2010
Abiomed Announces Specialized Partner Program for Heart Recovery in the Treatment of Emergent Cardiac Care Patients
Devices Cardiology
 HSMN NewsFeed - 30 Sep 2010
Concentric Medical Announces Initiation of the First Stentriever Study in Europe
Devices Neurology Interventional
 HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Sep 2010
Tryton Announces Positive Six-Month Results for Side Branch Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Sep 2010
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2010
Cook Medical Files Pre-Market Approval Application for FDA Approval of A Balloon Expandable Stent for Renal Artery Disease
Devices Interventional FDA
 HSMN NewsFeed - 24 Sep 2010
Patient Enrollment Completed in First Randomized Clinical Study of OrbusNeich's Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2010
Abbott's XIENCE V(R) Shows Outstanding Two-Year Clinical Results Versus TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Boston Scientific's TAXUS(R) Element Stent Demonstrates Strong Outcomes in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Sep 2010
Elixir Medical Corporation Initiates Enrollment in the EXCELLA BD Randomized Clinical Trial of the Elixir Novolimus Eluting Coronary Stent System with Bioabsorbable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Sep 2010
Tryton Completes $20 Million Financing to Accelerate U.S. Pivotal Trial
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Tryton Announces Launch in Several European and Eastern European Countries
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Sep 2010
Terumo Medical Corporation Announces First U.S. Patient Implant in Landmark Pilot Study Simultaneously Enrolling in the U.S. & Japan
Devices Interventional
 HSMN NewsFeed - 2 Sep 2010
Long Term Data Presented at ESC 2010 Further Support the Benefit of The CYPHER(R) Sirolimus Drug-Eluting Stent Compared to The ENDEAVOR(R) Zotarolimus-Eluting Stent in Important High-Risk Subgroups
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2010
Cardiogenesis Comments on the STAR-Heart Study Presented at European Society of Cardiology (ESC) 2010 Congress
Regenerative Medicine Devices Cardiology
 HSMN NewsFeed - 31 Aug 2010
New 2010 ESC Guidelines for Percutaneous Coronary Interventions Reinforce Importance of FFR in Treatment of Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Aug 2010
Boston Scientific Begins Clinical Trial Enrollment for New Coronary Stent with Bioabsorbable Polymer and Everolimus Drug Coating
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jul 2010
Concentric Medical Announces First Stroke Patients Treated With the Merci Retriever(R) in Japan
Devices Neurology
 HSMN NewsFeed - 21 Jun 2010
Data Show OrbusNeich's Genous Bio-engineered R stent is Safe and Effective in Combination with Drug-Eluting Balloon
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jun 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 SF Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 11 Jun 2010
Cook Medical Files Pre-Market Approval Application for FDA Approval of Zilver(R) PTX(R) Drug-Eluting Stent Platform
Devices Interventional
 HSMN NewsFeed - 10 Jun 2010
Boston Scientific Announces European Launch and First Implants of Platinum Chromium TAXUS(R) Element Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbott's Carotid Stent System and Surgery
Devices Interventional
 HSMN NewsFeed - 26 May 2010
Data Presented at EuroPCR 2010 Demonstrate Effectiveness of OrbusNeich's Genous Bio-engineered R stent in Diabetic Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 May 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Tryton Announces Positive Data from Side Branch System Presented in Symposium at EuroPCR 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
NEVO Sirolimus-eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
Devices Interventional Cardiology
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2010
Boston Scientific Announces Schedule for EuroPCR 2010
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2010
Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
Devices Interventional FDA
 HSMN NewsFeed - 6 May 2010
The New England Journal of Medicine Publication of SPIRIT IV Trial Results Confirm Superior Safety and Efficacy of Abbott's XIENCE V(R) Drug Eluting Stent Compared to TAXUS
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2010
Reverse Medical Corporation Successfully Completes Series B Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the CYPHER(R) Sirolimus Drug-Eluting Stent over the Endeavor(R) Zotarolimus-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Mar 2010
PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific's Novel Platinum Chromium TAXUS(R) Element(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Feb 2010
SCAI Statement on the CREST Study Findings: Carotid Stenting Is as Safe and Effective as Carotid Surgery in Patients at Risk for Stroke
Devices Interventional Neurology
 HSMN NewsFeed - 11 Feb 2010
OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Jan 2010
Cardium Provides Update on Commercial Development Plans for Generx Angiogenic Therapy for Heart Disease at 2010 Cell & Gene Therapy Forum
Biopharmaceuticals Cardiology Regenerative Medicine
 HSMN NewsFeed - 19 Jan 2010
Cardica's C-Port(R) Flex-A(R) Anastomosis System to Be Used for Development of Surgical Robot in Japan
Devices Surgery Cardiology
 HSMN NewsFeed - 13 Jan 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 13 Jan 2010
Published Study Demonstrates Effectiveness of Spectranetics Turbo-Booster(R) for Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Devices Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 16 Dec 2009
Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Dec 2009
OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Nov 2009
Atrium Announces 100th Patient Was Enrolled in the iCARUS Trial
Devices Interventional
 HSMN NewsFeed - 17 Nov 2009
New Genomic Test for Coronary Artery Disease Now Available at The Heart & Vascular Center of Arizona
Diagnostics Cardiology
 HSMN NewsFeed - 10 Nov 2009
PLC Systems Announces Distribution Agreement for RenalGuard(R) in Brazil
Devices Distribution Interventional
 HSMN NewsFeed - 9 Nov 2009
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
Devices Interventional
 HSMN NewsFeed - 7 Oct 2009
Penumbra, Inc. Enrolls First Patient in the START Clinical Trial to Define Image Guided Patient Selection Criteria for Interventional Acute Ischemic Stroke Treatment
Devices Interventional Radiology Neurosurgery Neurology
 HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
Elixir Medical Corporation Announces Positive First-In-Man Results for Three Drug Eluting Coronary Stent Systems with Durable and Bioabsorbable Polymers
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Final 12 Month Clinical Data from 5,000 Patients in Worldwide e-HEALING Clinical Study Show Good Safety and Efficacy with Real World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
TAXUS(R) Liberte(R) Stent Continues to Demonstrate Significant Improvements Over TAXUS(R) Express(R) Stent in Small Vessels and Long Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters
Devices Interventional Neurology
 HSMN NewsFeed - 22 Sep 2009
Pathway Medical Technologies Sees 172 Percent Growth over Last 2 Quarters with Jetstream Revascularization Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Sep 2009
Abiomed Presents Results from USpella; First U.S. Registry Data Evaluating 181 Patients from 16 Centers with IRB Approval
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Sep 2009
Brennen Medical Announces Sale of XenMatrix(R)
Devices Surgery Acquisitions
 HSMN NewsFeed - 14 Sep 2009
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 11 Sep 2009
PLC Medical Systems Reports Strong Success for RenalGuard(R) at ESC 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Sep 2009
Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2009
First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Aug 2009
sanofi-aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Aug 2009
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Aug 2009
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 20 Aug 2009
Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
Devices Regenerative Medicine
 HSMN NewsFeed - 30 Jul 2009
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
Devices Cardiology
 HSMN NewsFeed - 30 Jun 2009
Tryton Announces First Patient Enrollment in E-Tryton 150 Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Jun 2009
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Jun 2009
BARI 2D Study Presented at American Diabetes Association Scientific Sessions Underscores Utility of SPECT Myocardial Perfusion Imaging in Identifying Cardiovascular Risk and Evaluating Treatment Outcomes for Patients with Type 2 Diabetes
Biopharmaceuticals Radiology Cardiology
 HSMN NewsFeed - 7 Jun 2009
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
Devices Interventional Cardiology
 HSMN NewsFeed - 27 May 2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 21 May 2009
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2009
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 20 May 2009
Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 20 May 2009
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF Capital
Devices Venture Capital
 HSMN NewsFeed - 19 May 2009
NEVO Sirolimus-Eluting Coronary Stent Yields Superior Results to Taxus Liberte Stent in Pivotal Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
SYNTAX Substudy Shows Positive Outcomes for Left Main Patients Treated With TAXUS(R) Express2(R) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 May 2009
Boston Scientific Welcomes Launch of Syntax Score Website
Devices Cardiology
 HSMN NewsFeed - 19 May 2009
Invatec Receives CE Mark Approval for the IN.PACT Admiral Drug Eluting Balloon
Devices Interventional Regulatory
 HSMN NewsFeed - 15 May 2009
Boston Scientific Announces Schedule for EuroPCR 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2009
PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 May 2009
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 7 May 2009
New Study Shows that Zilver PTX from Cook Medical Effectively Treats Blockages in Critical Thigh Artery
Devices Interventional
 HSMN NewsFeed - 7 May 2009
SCAI Releases Consensus Statement on Length of Stay Following Elective Percutaneous Coronary Intervention
Devices Interventional Cardiology
 HSMN NewsFeed - 4 May 2009
PLC Systems Announces First Distribution Agreement in Spain for RenalGuard(R)
Devices Distribution
 HSMN NewsFeed - 30 Apr 2009
Cardica Develops the Cardica Microcutter, The First True Multi-Fire Endolinear Cutter
Devices Surgery
 HSMN NewsFeed - 22 Apr 2009
Abiomed Receives FDA 510(k) Clearance for Impella 5.0 and Impella LD
Devices Cardiology FDA
 HSMN NewsFeed - 22 Apr 2009
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
Devices Interventional Cardiology
 HSMN NewsFeed - 9 Apr 2009
New Clinical Data at ACC09 Show the CYPHER Sirolimus-eluting Coronary Stent Outperformed TAXUS LIBERTE and ENDEAVOR Stents in Key Outcome Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2009
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Devices Interventional
 HSMN NewsFeed - 31 Mar 2009
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2009
St. Jude Medical and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2009
Pathway Medical Technologies Secures $40 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 30 Mar 2009
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
Devices Regulatory Interventional Cardiology
 HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 24 Mar 2009
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 10 Mar 2009
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Mar 2009
CYPHER Sirolimus-eluting Coronary Stent Demonstrates Sustained Benefits Compared to Bare-Metal Stents in Six-Year Randomized Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 19 Feb 2009
CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Feb 2009
Bard Receives FDA Approval for the LifeStent Vascular Stent
Devices Interventional FDA
 HSMN NewsFeed - 5 Feb 2009
Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 2 Feb 2009
Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Jan 2009
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Jan 2009
Spectranetics Reports on 12-Month CELLO Data at LINC Meeting in Leipzig, Germany
Devices Interventional
 HSMN NewsFeed - 20 Jan 2009
Volcano Highlights Commitment, Market Acceptance of FFR Product Line
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Jan 2009
Cleveland Clinic to Present Results from Study Using Ivivi Technologies' tPEMF(tm) on Cardiac Ischemia At American College of Cardiology Annual Meeting
Devices Cardiology
 HSMN NewsFeed - 17 Dec 2008
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Dec 2008
FDA Approves Boston Scientific's Express(R) SD Renal Stent System
Devices Interventional FDA
 HSMN NewsFeed - 2 Dec 2008
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 26 Nov 2008
PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.
Devices Interventional FDA
 HSMN NewsFeed - 12 Nov 2008
Medtronic Launches Endeavor® Sprint Drug-Eluting Stent System on Rapid Exchange in United States
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2008
Elixir Medical Corporation Announced Positive First-In-Man Results from Three Drug Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Oct 2008
Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles
Devices Interventional Cardiology
 HSMN NewsFeed - 14 Oct 2008
Endeavor(R) Vs. Taxus(R): Medtronic's Drug-Eluting Coronary Stent Linked to Fewer Heart Attacks at Two Years Post Implant
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
Abbott's XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Oct 2008
12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 12 Oct 2008
Medtronic's Third-Generation Endeavor(R) Resolute Drug-Eluting Stent Maintains Strong Efficacy and Safety Profile at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Oct 2008
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 8 Oct 2008
Brennen Medical, LLC Launches XenMatriX(R) for Abdominal Wall (Hernia) Repair
Devices
 HSMN NewsFeed - 30 Sep 2008
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 15 Sep 2008
Wright Medical Announces Launch of BIOTAPE XM(TM) Reinforcement Matrix
Devices Orthopaedic
 HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 10 Sep 2008
Cook Medical Completes Enrollment in First International Trial of First-of-Its-Kind Drug-Eluting Peripheral Stent
Devices Interventional
 HSMN NewsFeed - 9 Sep 2008
Cardica Receives 510(k) Clearance to Market PAS-Port(R) Proximal Anastomosis System for Use in Cardiac Bypass Surgery
Devices Cardiology FDA
 HSMN NewsFeed - 4 Sep 2008
Clinical Data Indicate that Percutaneous Coronary Intervention with the CYPHER(R) Sirolimus-eluting Coronary Stent Is Comparable to Bypass Surgery in Key Safety Measures in Patients with Diabetes and Multi-Vessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2008
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 2 Sep 2008
First Patient Enrolled in Study Evaluating S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in Leg Disease
Devices Interventional
 HSMN NewsFeed - 1 Sep 2008
SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2008
SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2008
Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First 'Real World, All Comers' Clinical Study
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Sep 2008
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
Devices Interventional Cardiology
 HSMN NewsFeed - 28 Aug 2008
The CYPHER(R) Sirolimus-eluting Coronary Stent Outperforms the Taxus(R) Stent in People with Diabetes According to Clinical Data in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2008
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2008
Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Aug 2008
OrthoLogic Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jul 2008
Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Jul 2008
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 18 Jun 2008
Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
Devices Cardiology Regenerative Medicine
 HSMN NewsFeed - 11 Jun 2008
Interim Results for the Zilver(R) PTX(TM) Clinical Study from Cook Medical Show Promise for Improving the Treatment of Blockages in the Femoropopliteal Artery
Devices Interventional
 HSMN NewsFeed - 2 Jun 2008
Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 30 May 2008
PLC Systems Announces Approval of First European Study to Evaluate RenalGuard(TM)
Devices Interventional Cardiology
 HSMN NewsFeed - 28 May 2008
Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons
Devices Cardiology Surgery
 HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 May 2008
Boston Scientific Announces Launch of Expanded Size Range of FilterWire EZ(TM) Embolic Protection System
Devices Interventional
 HSMN NewsFeed - 15 May 2008
International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2008
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 14 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Reduces Major Adverse Cardiac Events in Small Vessel Patients Out to One Year
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
ENDEAVOR II Four-Year Results Demonstrate Long-Term Safety and Durable Efficacy of Medtronic Drug-Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 13 May 2008
Thrombus Aspiration before Stenting Benefits Patients Suffering Myocardial Infarction, Study Shows
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2008
Medtronic Announces Start of International Study Comparing Endeavor(R) Resolute Drug-Eluting Stent to Abbott's Xience(R) V
Devices Interventional Cardiology
 HSMN NewsFeed - 12 May 2008
PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008
Devices Interventional Cardiology
 HSMN NewsFeed - 1 May 2008
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2008
Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 1 Apr 2008
TAXUS(R) Stent Demonstrates Similar Outcomes in Diabetic Patients Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V Trials
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Apr 2008
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
Tryton Medical, Inc. Closes $14 Million Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 31 Mar 2008
Lotrel, a Single-Pill Combination for Treating High Blood Pressure, Reduced Cardiovascular Events by 20% in High-Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 31 Mar 2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Devices Interventional Cardiology
 HSMN NewsFeed - 31 Mar 2008
Abbott's XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Three Year Follow-up Data Suggest Better Outcomes Were Maintained with the CYPHER(R) Sirolimus-Eluting Coronary Stent Compared to Brachytherapy in Patients with In-Stent Reblockage
Devices Interventional Cardiology
 HSMN NewsFeed - 30 Mar 2008
Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Tailored Clopidogrel Dosing Improves PCI Outcomes
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 29 Mar 2008
Angiomax Demonstrated Improved Outcomes in Acute Heart Attack Patients Undergoing Primary Angioplasty Independent of Individual Risk Factors
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 28 Mar 2008
PLC Systems Announces First International Distribution Agreement for RenalGuard(TM)
Devices Radiology Interventional Distribution
 HSMN NewsFeed - 20 Mar 2008
PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Devices FDA
 HSMN NewsFeed - 19 Mar 2008
Cook Medical Announces the Launch and First Patient Enrollment of the REFORM Clinical Trial
Devices Interventional
 HSMN NewsFeed - 11 Mar 2008
Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 27 Feb 2008
Medtronic Announces First Human Use of Its Bifurcation Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 15 Feb 2008
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
Devices Interventional Cardiology
 HSMN NewsFeed - 11 Feb 2008
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Feb 2008
Mitralign Successfully Completes First Human Case
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Feb 2008
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 1 Feb 2008
Abbott Gains Reimbursement for XIENCE(TM) V Drug Eluting Stent in France
Devices Reimbursement Interventional Cardiology
 HSMN NewsFeed - 30 Jan 2008
Cardica's C-Port Anastomosis Systems for Coronary Artery Bypass Graft Procedures to be Used to Train Cardiothoracic Surgeons at Society of Thoracic Surgeons (STS) University
Devices Cardiology Surgery
 HSMN NewsFeed - 14 Jan 2008
Patients Treated with Lipitor Were Significantly Less Likely to Have a Cardiovascular Event Than Those Treated with Simvastatin, New Observational Study Shows
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Jan 2008
Merck/Schering-Plough Pharmaceuticals Provides Results of the ENHANCE Trial
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 10 Jan 2008
OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Regenerative Medicine
 HSMN NewsFeed - 7 Jan 2008
Penumbra, Inc. Announces 510(k) Clearance of the Penumbra System(TM) for Use in the Revascularization of Patients With Acute Ischemic Stroke
Devices Neurology Interventional FDA
 HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 19 Dec 2007
PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
Biopharmaceuticals Radiology Interventional
 HSMN NewsFeed - 13 Dec 2007
FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-prescription MEVACOR(R) (lovastatin) 20 mg
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Dec 2007
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Nov 2007
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29
Devices Interventional Cardiology
 HSMN NewsFeed - 26 Nov 2007
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2007
Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
Devices Cardiology FDA
 HSMN NewsFeed - 8 Nov 2007
New Data Show MIV Therapeutic's Vestasync Drug Eluting Stent Produces Less Fibrinoid and Equivalent Efficacy When Compared to Other Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2007
COURAGE Sub-study: PCI Outperforms Drugs-Only
Devices Interventional Cardiology
 HSMN NewsFeed - 6 Nov 2007
Lipitor Provides Greater Benefit Compared to simvastatin in Patients with a History of Heart Attacks Who Have Had Subsequent Cardiovascular Events
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 5 Nov 2007
Pooled Analysis of Long-Term Data Suggests Cypher(R) Sirolimus-Eluting Coronary Stent Provides Sustained Clinical Benefits in Patients with Coronary Artery Disease Compared to Bare Metal Stents
 HSMN NewsFeed - 5 Nov 2007
Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 4 Nov 2007
In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 2 Nov 2007
Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
Devices Licensing Interventional
 HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 24 Oct 2007
Spectranetics Announces Clinical Data From Cello Trial
Devices Interventional
 HSMN NewsFeed - 23 Oct 2007
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott Announces Positive One-Year Results from the World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Medtronic Receives CE Mark for Endeavor(R) Resolute Drug-Eluting Stent
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 22 Oct 2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
New Long-Term Data Suggest Clinical Differences in Safety and Efficacy between CYPHER(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
PLC Medical Systems to Introduce RenalGuard(TM) at TCT 2007
Devices Interventional
 HSMN NewsFeed - 22 Oct 2007
Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Oct 2007
Schering-Plough Reports Two Phase II Studies of Thrombin Receptor Antagonist (TRA) Build on Findings from Previous Phase II Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 21 Oct 2007
New Study Shows Excellent Outcomes for CYPHER(R) Sirolimus-Eluting Coronary Stent in Treatment of Completely Blocked Coronary Arteries
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Oct 2007
Cordis Corporation Announces Clinical Studies and Events at TCT 2007
Devices Interventional Cardiology
 HSMN NewsFeed - 16 Oct 2007
Novadaq launches PINPOINT: Company's first minimally invasive imaging system
Devices Surgery
 HSMN NewsFeed - 10 Oct 2007
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 5 Oct 2007
Medtronic to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Oct 2007
Novadaq Resumes Normal Business Operations by Securing ICG for SPY
Devices Surgery Radiology
 HSMN NewsFeed - 1 Oct 2007
TherOx(TM) Announces Completion of Pivotal Trial
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Sep 2007
Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
Devices Interventional
 HSMN NewsFeed - 21 Sep 2007
The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms the Taxus Stent in Small Coronary Vessels According to New Clinical Data Analysis Published in the Journal of the American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Sep 2007
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2007
Penumbra, Inc. Completes Pivotal Stroke Trial of Intracranial Revascularization
Devices Interventional Radiology Neurology
 HSMN NewsFeed - 5 Sep 2007
REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
Cardiology
 HSMN NewsFeed - 5 Sep 2007
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2007
Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2007
Patients Who Switched from Established Lipitor Therapy to Simvastatin Experienced a Significant 30 Percent Increase in Relative Risk of Cardiovascular Events or Death, New Observational Study Shows
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 Sep 2007
Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Sep 2007
Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 3 Sep 2007
Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Aug 2007
Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
Devices Cardiology
 HSMN NewsFeed - 31 Jul 2007
Endocrinologists Welcome FDA Avandia Recommendation
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 31 Jul 2007
Micrus Endovascular Signs Letter of Intent to Acquire Revascularization Technology to Treat Ischemic Stroke
Devices Interventional Neurology
 HSMN NewsFeed - 19 Jul 2007
Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2007
Angiotech's corporate partner, Boston Scientific, announces first human use of TAXUS(R) Petal(TM) Bifurcation Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 18 Jul 2007
FDA Grants Fast Track Designation to Cardium's Phase 3 Angiogenic Gene Therapy for Heart Disease
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 17 Jul 2007
Boston Scientific Announces First Human Use of TAXUS(R) Petal(TM) Bifurcation Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 27 Jun 2007
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
Regenerative Medicine
 HSMN NewsFeed - 25 Jun 2007
Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 25 Jun 2007
Ranbaxy Launches Pravastatin Sodium 80 Mg Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Jun 2007
Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 Jun 2007
Newly Published Data From Large Study Support Cardiovascular Safety of Avandia (rosiglitazone maleate)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 4 Jun 2007
Positive Results for Second-Generation Taxus(R) Liberte(TM) Coronary Stent System Highlighted in Journal of American College of Cardiology
Devices Interventional Cardiology
 HSMN NewsFeed - 30 May 2007
Data Affirms Avandia (Rosiglitazone maleate) Cardiovascular Safety Profile
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 23 May 2007
Efficacy of OrbusNeich's Genous(TM) Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
SPIRIT Clinical Data Reaffirm Strength of TAXUS(R) and PROMUS(TM) Drug-Eluting Coronary Stent Systems
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
Devices Interventional Cardiology
 HSMN NewsFeed - 22 May 2007
Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
Devices Interventional Cardiology
Return to NewsFeed  

 Additional items found! 358

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 358 additional stories matching:
Revascularization
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.